ORKA Latest Press Releases

-- September 23, 2026 --

Oruka Therapeutics Announces Positive Week 28 Data for ORKA-001 from the Ongoing EVERLAST-A Trial Showing Deepening of Responses Without Additional Dosing Globe Newswire 7:00 AM

-- September 9, 2026 --

Oruka Therapeutics to Attend the 2026 Morgan Stanley Global Healthcare Conference Globe Newswire 4:01 PM

-- August 24, 2026 --

Oruka Therapeutics Appoints Todd Edwards as Chief Commercial Officer Globe Newswire 4:01 PM

-- August 10, 2026 --

Oruka Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update Globe Newswire 7:03 AM

-- May 28, 2026 --

Phase 2 Data could Transform these Biotechs from Clinical Promise to Market Validation Globe Newswire 8:35 AM

Oruka Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference Globe Newswire 8:00 AM

-- May 13, 2026 --

Oruka Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update Globe Newswire 4:03 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software